The U.S. Food and Drug Administration concluded 2024 with 50 new drug approvals, marking a year of significant progress in treating various diseases. Among the notable approvals were the first-ever treatments for metabolic dysfunction-associated steatohepatitis (MASH) and Niemann-Pick disease type C. The FDA also cleared several other groundbreaking medications, including the first novel treatment for schizophrenia in decades and the first drugs targeting the root cause of pulmonary arterial hypertension.
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.The U.S. Food and Drug Administration wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments.of new treatments not previously approved or marketed in the U.S. The total drugs cleared dipped slightly from 55 in 2023, but there were several firsts and other notable medications that the agency gave a green light last year.
Accolade offers care delivery, navigation and advocacy services. The company went public during the coronavirus pandemic in 2020 as investors began pouring billions of dollars into digital health, but the stock has mostly been in freefall in the years since. Accolade is the latest in a string of digital health companies to
"Combining Transcarent's complex care experience with Accolade's people and 16 years of healthcare data, we will create a more personalized healthcare experience for people while improving outcomes and driving down costs," Accolade CEO Rajeev Singh said in a statement Wednesday.
FDA Approvals New Drugs Healthcare Medicine Treatments
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
iPad Mini (2024) vs iPad Air (2024): Which One is Right for You?Apple's 2024 iPad lineup includes a refreshed iPad mini and a new iPad Air with two screen sizes. This comparison helps you decide between these two popular models.
Read more »
2024 Lookback: ‘Mufasa’ Meltdown Caps Unpredictable 2024 Box OfficeRevisiting 2024 box office predictions highlights missed expectations for “Mufasa,” “Joker,” “Inside Out 2,” “Deadpool” and more
Read more »
Top luxury campaigns of 2024: LVMH and Paris 2024The corporation's wine and spirits division Moët Hennessy, beauty retailer Sephora and jeweler Chaumet are among the brands that supported the premium partnership.
Read more »
Missouri Women's Ends 2024 with a Roar: The Buzz, Monday, Dec. 30, 2024Your daily briefing on what's going on with Mizzou athletics, including full TV listings.
Read more »
2024 Still on Track to Be First Full Year That Breached 1.5°CEloise Goldsmith is a staff writer for Common Dreams.
Read more »
Jazz Assign 2024 First-Round Pick to G-LeagueIsaiah Collier will be spending some time with the Salt Lake City Stars.
Read more »